Advertisement
Australia markets open in 7 hours 19 minutes
  • ALL ORDS

    8,019.40
    -3.30 (-0.04%)
     
  • AUD/USD

    0.6611
    +0.0006 (+0.10%)
     
  • ASX 200

    7,750.00
    +1.00 (+0.01%)
     
  • OIL

    78.97
    +0.71 (+0.91%)
     
  • GOLD

    2,341.40
    -33.60 (-1.41%)
     
  • Bitcoin AUD

    95,761.81
    +2,409.11 (+2.58%)
     
  • CMC Crypto 200

    1,300.80
    +40.60 (+3.22%)
     

Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Autolus Therapeutics plc
Autolus Therapeutics plc

LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its first quarter 2024 financial results and operational highlights before open of US markets on Tuesday, May 14, 2024.

Management will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.

A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.

ADVERTISEMENT

Contact:

Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com

Julia Wilson
+44 (0) 7818 430877 
j.wilson@autolus.com

Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303 
susan@sanoonan.com